CORONA Remedies Limited (NSE: CORONA), ISIN INE02ZQ01018 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
CORONA last traded at ₹2106.60 (+0.04%), with a 52-week range of ₹1336.95 to ₹2139.55 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 69.00%, FIIs 3.63%, DIIs 12.90%, mutual funds 12.50%.
EquiSense Score (ECS): 84/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.